About Us
Our Company
Management & Board
Aceragen
Tilsotolimod
Toll-Like Receptor Activation
Publications & Presentations
Investor Relations
×
Intratumoral IMO-2125 Treatment in Combination with Anti-CTLA-4 mAB Induces Durable Anti-tumor Responses Associated with Tumor-specific Memory in Preclinical Studies
